Physician profile
John A Boudreau
NPI 1053338640
$966.34
in general payments reported to CMS, 2019-2025
8 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.70 · 2022: $20.51 · 2023: $443 · 2024: $140 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $669.87 | 2022-2025 | Na, Motoband |
| Stryker Corporation | $96.85 | 2023-2024 | T2 Alpha |
| Osteocentric Technologies, INC. | $74.92 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Sirtex Medical INC | $39.48 | 2023 | Sir-Spheres Microspheres |
| Organogenesis INC. | $24.08 | 2024 | |
| Kerecis Limited | $22.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ebi, LLC | $20.74 | 2025 | Biomet Ebi Bone Healing System |
| Ethicon US, LLC | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boudreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.